Drug firm Lupin today said it has launched a generic version of Pennsaid, used to treat pain in the knees caused by osteoarthritis in the American market.
The company's product -- Diclofenac Sodium Topical Solution 2 per cent -- is the generic version of Horizon Pharma Therapeutics Pennsaid, Lupin said in a statement.
As per IQVIA MAT October 2022 data, Lupin said diclofenac sodium topical solution, 2 per cent, had estimated annual sales of $509 million in the US.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
